This page updated:
1/27/2007 9:23:00 AM
DoctorFungus - All Rights Reserved
© 2007 Copyright
Site built and designed for doctorfungus by Webillustrated
You are here:
Fungal infections have emerged as a significant clinical problem in recent years. Due to the increasing frequency of fungal infections, mycology is today undergoing a true renaissance. Although not fully sufficient yet, we have novel tools for diagnosis. While the conventional methods of cultivation and histopathology remain the gold standards for diagnosis, the progressions in molecular mycological methods have markedly influenced the concept of rapid diagnosis.
Therapeutic modalities have also evolved. The development of novel antifungal agents, including agents of entirely new classes, is noteworthy. Finally, the development of the standard in vitro susceptibility testing procedures for yeasts  and moulds  has established a process for estimation of likely clinical outcome by in vitro susceptibility testing results. This provides increasingly useful ways to determine susceptibility patterns for each of the fungi.
For more details, see:
1622. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard. NCCLS document M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
1623. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.